- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
PLAY BUTTON
PLAY BUTTON
126 Cards in this Set
- Front
- Back
|
QUARANTINE REGULATIONS ARE INTENDED TO PREVENT THE INTRODUCTION AND DISSEMINATION, DOMESTICALLY OR INTERNATIONALLY ORIGINATED, OF DISEASES AFFECTING WHAT
|
1) HUMANS, PLANTS AND ANIMALS
2) PROHIMITED OR ILLEGALLY TAKEN WILDLIFE 3) ARTHROPOD VECTORS 4) PESTS OF HEALTH & AGRICULTURAL IMPORTANCE |
|
AN ACUTE, DIARRHEAL ILLNESS CAUSED BY INFECTION OF THE INTESTINE WITH THE BACTERIUM VIBRIOCHOLERAE
|
CHOLERA
|
|
APRROXIMATELY ONE IN EVERY HOW MANY PEOPLE HAVE SEVERE DISEASE CHARACTERIZED BY PROFUSE WATERY DIARRHEA, VOMITING AND LEG CRAMPS
|
20
|
|
WITHOUT TREATMENT FOR CHOLERA, DEATH CAN OCCUR IN HOW LONG
|
HOURS
|
|
IN A CHOLERA EPIDEMIC, THE SOURCE OF THE CONTAMINATION IS USUALLY WHAT
|
THE FECES OF AN INFECTED PERSON
|
|
THE CHOLERA BACTERIUM MAY ALSO LIVE IN WHAT ENVIRONMENT
|
THE BRACKISH RIVERS AND COASTAL WATERS
|
|
AN INFECTIOUS DISEASE OF ANIMALS AND HUMANS CAUSED BY A BACTERIUM NAMED YERSINIA PESTIS
|
PLAGUE
|
|
PEOPLE USUALLY GET THE PLAGUE FROM WHAT
|
BEING BITTEN BY A RODENT FLEA THAT IS CARRYING THE PLAGUE BACTERIUM
|
|
WHAT ARE THE CLINICAL FORMS THAT THE PLAGUE COMES IN
|
BUBONIC AND PNEUMONIC
|
|
VERY RARE CAUSE OF ILLNESS IN TRAVELERS, BUT MOST COUNTRIES HAVE REGULATIONS AND REQUIREMENTS FOR THIS VACCINATION PRIOR TO ENTERING THE COUNTRY
|
YELLOW FEVER
|
|
A VIRAL DISEASE TRANSMITTED BETWEEN HUMANS BY A MOSQUITO
|
YELLOW FEVER
|
|
HOW LONG IS THE VACCINATION FOR YELLOW FEVER GOOD FOR
|
10 YEARS
|
|
WHAT VACCINATION IS ONLY ADMINISTERED AT DESIGNATED VACCINATION CENTERS; THE LOCATIONS OF WHICH CAN USUALLY BE GIVEN BY THE LOCAL HEALTH DEPARTMENT
|
YELLOW FEVER
|
|
THE LAST NATURALLY ACQUIRED CASE OF SMALLPOX IN THE WORLD OCCURED WHEN AND IN WHAT COUNTRY
|
OCTOBER 1977 IN SOMALIA
|
|
WHEN WAS GLOBAL ERADICATION OF SMALLPOX WAS CERTIFIED WHEN BY THE W.H.O.
|
1979
|
|
ALL KNOWN VARIOLA VIRUS STOCKS ARE HELD UNDER SECURITY WHERE
|
THE CDC AND AT THE CENTRE OF VIROLOGY AND BIOTECHNOLOGY IN RUSSIA
|
|
WHAT IS A SYSTEMIC VIRAL DISEASE GENERALLY PRESENTING WITH A CHARACTERISTIC SKIN ERUPTION
|
SMALLPOX
|
|
HOW DO YOU IMMUNIZE AGAINST SMALLPOX
|
THE VACCINIA VIRUS
|
|
WHAT NAVY INSTRUCTION IN THE (QUARANTINE REGULATIONS OF THE NAVY)
|
OPNAVINST 6210.2
|
|
PROVIDES GUIDANCE ON NAVY'S RESPONSIBILITIES, LIAISONS, FOREIGN QUARANTINE AND PUBLIC HEALTH REQUIREMENTS
|
OPNAVINST 6210.2
|
|
WHAT CHAPTER OF THE P-5010 COVERS NAVY ENTOMOLOGY AND PEST CONTROL TECHNOLOGY
|
CHAPTER 8
|
|
SHIPBOARD SANITATION CERTIFICATE PROGRAM
|
BUMEDNOTE 6210
|
|
WHAT IDENTIFIES NAVY MEDICAL PERSONNEL DELEGATED AUTHORITY IN ACCORDANCE WITH OPNAVINST 6210.2 AND THE W.H.O., INTERNATIONAL HEALTH REGULATIONS (IHR'S) TO INSPECT AND ISSUE APPROPRIATE SHIP SANITATION CERTIFICATES (SSC) AND TO PROVIDE RELATED STANDARD PROCEDURES AND POLICY FOR THE SHIP SANITATION CERTIFICATE PROGRAM (SSCP)
|
BUMEDNOTE 6210
|
|
THE COMMANDING OFFICER WILL HAVE BETWEEN HOW MANY HOURS PRIOR TO ENTERING A PORT TO MESSAGE/RADIO THE SENIOR NAVAL OFFICER IN COMMAND OF THE PORT TO BE ENTERED
|
12-72
|
|
WHAT IS THE APPROVED MATERIAL FOR A TUBERCULIN TEST
|
TUBERCULIN, PURIFIED PROTEIN DERIVATIVE (PPD)
|
|
WHAT IS A PREMIXED TWEEN-80 STABILIZED INTERMEDIATE STREGTH
|
PPD (5TU)
|
|
WHAT IS USED TO ADMINISTER A PPD
|
1ML TUBERCULIN SYRINGE
|
|
WHAT TYPE OF NEEDLE IS A TUBERCULIN SYRINGE FITTED WITH
|
25-GUAGE 5/8-INCH NEEDLE
|
|
WHAT IS THE FDA APPROVED BLOOD TEST FOR TUBERCULOSIS
|
QUANTIFERON-TB GOLD (QFT)
|
|
WHAT IS THE BACTERIA THAT CAUSE LATENT TB INFECTION AS WELL ACTIVE TB DISEASE
|
MYCOBACTERIUM TUBERCULOSIS
|
|
AN ILLNESS IN WHICH TB BACTERIA ARE MULTIPLYING AND ATTACKING A PART OF THE BODY, USUALLY THE LUNGS
|
ACTIVE TB DISEASE
|
|
WHAT IS THE CONDITION IN WHICH TB BACTERIA ARE ALIVE BUT INACTIVE IN THE BODY
|
LATENT TB INFECTION (LTBI)
|
|
PEOPLE WITH LATENT TB INFECTION HAVE NO SYMPTOMS, DON'T FEEL SICK, CAN'T SPREAD TB TO OTHERS, AND USUALLY HAVE WHAT ELSE
|
A POSITIVE SKIN TEST REACTION
|
|
WHAT IS A TEST THAT IS OFTEN USED TO FIND OUT IF YOU ARE INFECTED WITH TB BACTERIA
|
TB SKIN TEST
|
|
A NEW TEST THAT USES A BLOOD SAMPLE TO FIND OUT IF YOU ARE INFECTED WITH TB BACTERIA
|
TB BLOOD TEST (QFT)
|
|
A VACCINE FOR TB NAMED AFTER THE FRENCH SCIENTISTS WHO DEVELOPED IT, CALMETTE AND GUERIN
|
BCG
|
|
WHAT IS A MORE DIRECT WAY OF HELPING PATIENTS TAKE THEIR MEDICINE FOR TB
|
DIRECTLY OBSERVED THERAPY (DOT)
|
|
THE ANTIBIOTIC REGIMEN OF CHOICE FOR TUBERCULOSIS PREVENTIVE THERAPY IS WHAT
|
INH
|
|
INH IS AN ORAL DAILY DOSE OF HOW MUCH MEDICATION AND FOR HOW LONG
|
5MG/KG (300MG MAX) FOR 9 MONTHS
|
|
WHAT IS AN ALTERNATE REGIMEN OF INH THAT IS TAKEN TWICE WEEKLY FOR 9 MONTHS
|
15MG/KG (900MG MAX)
|
|
WHEN IS INITIAL SCREENING (TB TESTING)
|
UPON ENTERING ACTIVE DUTY AND ALL INDIVIDUALS BEGINNING EMPLOYMENT AS CIVMAR FOR THE MSC
|
|
WHEN THE PERSON HAS A PAST HISTORY OF ACTIVE DISEASE, REACTION TO SKIN TEST, OR A HISTORY OF INH THERAPY, THEY MUST PROVIDE ADEQUATE DOCUMENTATION OF WHAT
|
1) PRIOR SKIN TESTS
2) CLINICAL EVALUATIONS 3) PERTINANT MEDICAL RECORDS |
|
WITHIN HOW LONG OF SEPARATION OR RETIREMENT MUST A SERVICE MEMBER RECEIVE A TB SKIN TEST
|
6 MONTHS
|
|
WHEN IS IT INDICATED TO HAVE A CHEST RADIOGRAPH DONE WRT TB TESTING
|
FOR NEW REACTORS TO RULE OUT ACTIVE DISEASE AND FOR NEW AND PREVIOUS REACTORS WHO ARE CONTACTS OF POTENTIALLY INFECTIOUS CASE OF ACTIVE DISEASE
|
|
WHAT IS THE APPROVED METHOD FOR ADMINISTERING A PPD
|
MANTOUX METHOD
|
|
IF THE RATE OF NEWLY IDENTIFIED CONVERTERS IS TWO TIMES GREATER THAN THE EXPECTED BASELINE CONVERSION RATE OF THE COMMAND (1-2%) PER YEAR FOR THE NAVY/MC, WHO DO YOU NEED TO CONTACT
|
NEPMU
|
|
A POSITIVE TST REACTION IN BCG IMMUNIZED INDIVIDUALS SHOULD BE REGARDED AS INDICATIVE OF WHAT
|
TB INFECTION
|
|
ALL TB REACTORS WITH AN INDURATION OF ___ MM OR GREATER MUST BE EVALUATED AND CONSIDERED FOR THERAPY FOR ISONIAZID (INH)
|
5 MM
|
|
TB REACTOR WITH INDURATION OF ___ MM OR MORE IS A CANDIDATE FOR INH THERAPY
|
15 MM
|
|
<15 MM REACTOR IS A CANDIDATE FOR THERAPY ONLY IF ONE OF THE CRITERIA OF WHAT INSTRUCTION APPLY
|
BUMEDINST 6224.8A, TABLE 1 (CRITERIA FOR DETERMINING A POSITIVE TST REACTION)
|
|
PRIOR TO THERAPY, THE REACTOR MUST BE EVALUATED BY WHO TO RULE OUT ACTIVE TB DISEASE
|
MO, NP, PA OR IDC
|
|
WHAT IS PERFORMED ON THOSE WHOSE INITIAL TST EVALUATION SUGGESTS AN ELEVATED RISK OF LIVER DISEASE OR INH-INDUCED HEPATOXICITY
|
BASELINE LIVER FUNCTION TESTS (SGOT/SGPT)
|
|
LFT TESTING - SHOULD BE OBTAINED AT LEAST 1, 2 AND 3 MONTHS AFTER INITIATING INH FOR WHAT
|
1) ALL 35 Y/O OR GREATER
2) TAKING PHENYTOIN (DILANTIN) 3) HEAVE ETOH CONSUMERS 4) CHRONIC LIVER DISEASE OR SEVERE RENAL DYSFUNCTION 5) PREGNANCY |
|
IF TREATMENT HAS BEEN INTERRUPTED FOR MORE THAN ____ MONTHS, PATIENTS MUST BE EXAMINED TO EXCLUDE ACTIVE DISEASE
|
2 MONTHS
|
|
DO NOT RESTART THE 9-MONTH DAILY INH REGIMEN IF AT LEAST ____ DOSES OF INH CAN BE ADMINISTERED WITHIN A 12-MONTH PERIOD
|
270 DAYS
|
|
INH THERAPY MAY DO WHAT TO THE LIVER ENZYMES (SGOT/SGPT) BLOOD LEVELS
|
INCREASE
|
|
CONSIDER WITHHOLDING IN IF A PATIENT'S ______ LEVELS EXCEED THREE TO FIVE TIMES THE UPPER LIMIT OF NORMAL
|
TRANSAMINASE
|
|
A CONTACT INVESTIGATION MUST BE INITIATED UPON DISCOVERY OF AN ACTIVE TB CASE IN AN EFFORT TO WHAT
|
PREVENT FURTHER PROPAGATION
|
|
UPON DISCOVERY OF A SUSPECTED OR CONFIRMED CASE OF ACTIVE TB, THE CO OR OIC MUST NOTIFY WHOM
|
COGNIZANT NEPMU
|
|
MER'S MUST BE SUBMITTED WITHIN HOW LONG OF SUSPICION/CONFIRMATION OF TB DIAGNOSIS
|
24 HOURS
|
|
WHAT DO YOU HAVE TO DO WHEN ACTIVE TB IS EITHER RULED IN OR OUT
|
SUBMIT A SECOND MER
|
|
WHO MUST VERIFY IN WRITING PERSONNEL WHO ARE TRAINED AND COMPETENT IN ADMINISTERING AND INTERPRETING THE RESULTS OF A TST
|
SMDR
|
|
TST'S MUST BE READ WITHIN HOW LONG
|
48-72 HOURS
|
|
HOW IS A TST RESULT READ WRT TO INDURATION
|
MEASURE INDURATION IN MM AT ITS WIDEST TRANSVERSE DIAMETER
|
|
WHERE DO YOU RECORD RESULTS OF A TST
|
NAVMED 6230/4 OR NAVMED 6230/5
|
|
ADSENCE OF INDURATION IS REPORTED AS WHAT
|
0 MM OR ZERO MM
|
|
WHAT ARE EXAMPLES OF WAYS NOT TO RECORD A TST
|
NEGATIVE, POSITIVE OR NONSIGNIFICANT
|
|
WHAT IS DONE WHEN A PERSON FAILS TO RETURN WITHIN 72 HOURS OF ADMINISTERING A TST
|
RECORD THE TEST AS "NOT READ" AND APPLY A TST ON THE OPPOSITE ARM
|
|
WHAT ARE SOME SYMPTOMS OF A PATIENT WITH ACTIVE TB DISEASE
|
WEAKNESS, WEIGHT LOSS, FATIGUE, FEVER, LOSS OF APPETITE, CHILLS AND NIGHT SWEATS
|
|
ISONIAZID, RIFAMPIN AND PYRAZINAMIDE ARE ANTITUBERCULOUS DRUGS CLASSIFIED AS WHAT
|
BACTERICIDAL
|
|
ETHAMBUTOL AND STREPTOMYCIN ARE ANTITUBERCULOUS DRUGS CLASSIFIED AS WHAT
|
BACTERIOSTATIC
|
|
CLINICAL TB MUST ALWAYS BE TREATED WITH AT LEAST HOW MANY DRUGS
|
TWO
|
|
THE PREFERRED TREATMENT FOR LATENT TB INFECTION IS WHAT
|
ING DAILY (300 MG FOR ADULTS, 10-20 MG/KG FOR CHILDREN) FOR 9 MONTHS
|
|
WHAT IS THE OFFICIAL SYSTEM TO CAPTURE, STORE AND COMMUNICATE INFORMATION RELATED TO RME'S
|
DISEASE REPORTING SYSTEM INTERNET (DRSI)
|
|
DRSI IS MANDATORY WHEN
|
WHERE THERE IS INTERNET CONNECTION
|
|
THE FOLLOWING COMMUNICABLE DISEASES ARE REQUIRED TO BE REPORTED WITHIN 24 HOURS
|
A SHIT TON!! READ THE LTG!!!
|
|
THE USE OF WHAT IS NO LONGER AUTHORIZED TO SUBMIT A MER
|
SAMS
|
|
SUBMIT ONLY ONE MER PER OUTBREAK UNLESS INSTRUCTED OTHERWISE BY WHO
|
NEPMU
|
|
WRT CLASSIFICATION, MER'S ARE USUALLY WHAT
|
UNCLASSIFIED
|
|
ALL MER'S SHOULD BE MARKED WHAT
|
"FOR OFFICIAL USE ONLY"
|
|
WHO IS REQUIRED TO SUBMIT THE REPORT FOR A REPORTABLE CASE/MEDICAL-EVENT
|
THE HEALTHCARE PROVIDER WHO DIAGNOSED OR IDENTIFIED
|
|
A DIAGNOSES, CASE, OR MEDICAL-EVENT BECOMES REPORTABLE ONCE IT HAS BEEN CLASSIFIED AS WHAT
|
SUSPECTED, PROBABLE OR CONFIRMED
|
|
WHAT IS THE DOSE INTERVAL FOR THE ANTHRAX VACCINE
|
0, 4 WEEKS, 6 MONTHS, 12 MONTHS, 18 MONTHS AND YEARLY BOOSTERS
|
|
WHAT ROUTE IS THE ANTHRAX VACCINE ADMINISTERED
|
IM
|
|
WHEN IS THE CHOLERA VACCINE REQUIRED
|
ONLNY WHEN REQUIRED BY THE HOST COUNTRY
|
|
WHAT IS THE ROUTE OF ADMINISTRATION FOR THE CHOLERA VACCINE
|
SQ OR IM
|
|
WHAT IS THE PERIODICITY OF THE CHOLERA VACCINE
|
EVERY 6 MONTHS IF RESIDING IN OR TRAVELING TO HIGHLY ENDEMIC AREA
|
|
THE HEPATITIS B VACCINE IS ADMINISTERED TO WHO
|
REQUIRED FOR HIGH RISK PERSONNEL SUCH AS;
- OCCUPATIONAL EXPOSURE TO BLOOD PRODUCTS OR OTHER BODY FLUIDS - ALL HEALTHCARE WORKERS - ALL HM STUDENTS - ANY PERSON WHO CANTACTS AN STD - HIGH RISK AREAS |
|
HOW MANY DOSES IS THE HBV VACCINE
|
3
|
|
WHAT IS THE MINIMUM INTERVAL FOR THE HBV VACCINE
|
ONE MONTH BETWEEN DOES 1 AND 2; 5 MONTHS BETWEEN DOES 2 AND 3
|
|
WHAT TYPES OF MER'S DO WE HAVE (I.E. WHAT ARE THE CLASSIFICATIONS)
|
- SUSPECTED
- PROBABLE - CONFIRMED |
|
WHAT ARE THE DOSAGES THAT INH ARE GIVEN IN
|
- 5MG/KG (300MG/DAY MAX) FOR NINE MONTHS (MUST ACCOMPLISH 270 DOSES WITHIN 9 MONTHS
- 15MG/KG (900MG/DAY MAX) TWICE WEEKLY FOR 9 MONTHS |
|
ONCE YELLOW FEVER IS RECONSTITUTED, IT MUST BE USED WITHIN HOW LONG
|
1 HOUR
|
|
WHAT IS THE STORAGE TEMPERATURE OF YELLOW FEVER
|
32 - 41 DEG F
|
|
ONCE MMR IS RECONSTITUTED, IT MUST BE USED WITHIN HOW LONG
|
8 HOURS
|
|
WHAT ARE THE ELEMENTS OF THE TB CONTROL PROGRAM
|
- SCREENING & TESTING
- MANAGEMENT FOR NEW POSITIVE TESTS - CONTANT INVESTION - PATIENT MANAGEMENT - REPORTS |
|
WHEN ARE CHEST X-RAYS PERFORMED WRT TB SCREENING
|
ON NEW REACTORS TO RULE OUT ACTIVE
|
|
WHAT IS THE ROUTE OF ADMINISTRATION FOR MMR
|
SUBCUTANEOUS
|
|
WHAT IS THE DOSAGE OF THE TST
|
0.1CC OR 5TU
|
|
DESCRIBE THE NEEDLE REQUIREMENTS FOR ADMINISTERING A TST
|
1ML TUBERCULIN SYRINGE WITH A 5/8" 25 GAUGE
|
|
WHAT ARE TWO SIGNIFICANT DATE/TIME PERIODS WRT SMALLPOX
|
OCTOBER 1977 LAST KNOWN OUTBREAK, AND ERATICATED 2 YEARS LATER
|
|
WHAT ARE THE STORAGE TEMPS REQUIREMENTS FOR MMR
|
-58 DEG F TO 46 DEG F
|
|
WRT POSITIVE TB RESULTS, WHAT TEST RESULTS REQUIRE WHAT ACTION
|
- 5MM OR GREATER MUST BE EVAL'D AND CONSIDERED FOR INH IF AT RISK.
- <15MM IS A CANDIDATE IF THEY MEET CRITERIA OUTLINED IN BUMEDINST 6224.8A - 15MM OR MORE IS A CANDIDATE FOR INH THERAPY |
|
WHAT IS THE PURPOSE OF A MER
|
ENABLES NAVY PUBLIC HEALTH EXPERTS TO BE AWARE OF;
- IMPORTANT MEDICAL EVENT WHEN THEY OCCUR - PREVENTION AND CONTROL ACTIONS ALREADY TAKEN BY OR BEING CONSIDERED BY LOCAL LEVEL MEDICAL STAFF |
|
WHEN IS A TB TEST REQUIRED TO BE ADMINISTERED
|
- UPON ACCESSION TO ACTIVE DUTY SERVICE
- BEING EMPLOYED BY CIVMAR (MSC) - PERIODIC SCREENINGS WITH PHA OR ANNUAL EXAM - 6 MONTH PRIOR TO RETIREMENT OR SEPARATION - INDIVIDUALS DEEMED TO BE AT RISK - DIRECTED BY COMBATANT COMMAND - IF RECOMMENDED BY NEPMU |
|
WHAT QUARANTIBABLE DISEASES ARE WE CONCERNED ABOUT WITH WHEN WE TRAVEL WORLDWIDE
|
- CHOLERA
- INFECTIOUS TB - DIPTHERIA - PLAGUE - YELLOW FEVER - SMALLPOX - VIRAL HEMORAGIC FEVER - SARS - CERTIAN INFLUENZA'S |
|
HOW WOULD YOU CONTROL CERTAIN QUARANTINABLE DISEASE
|
- EDUCATION
- RAT PROOFING - STORAGE AND DISPOSAL OF FOODS - PATIENT ISOLATION - CLOTHING REPELLANTS - CASE REPORTING |
|
WHAT IS A GOOD INDICATOR OF A TB CASE INFECTIVITY. I.E. SIGNIFICATN NEW REACTOR RATE
|
IF THE RATE OF NEWLY IDENTIFIED CONVERTERS IS TWO TIMES GREATER THAN THE EXPECTED BASELINE OF 1-2%
|
|
WHEN WOULD YOU CONSIDER WITHHOLDING INH FOR A PATIENT
|
IF A PATIENT'S TRANSAMINASE LEVELS ARE THREE TO FIVE TIMES THE UPPER LIMIT OF NORMAL
|
|
HOW DO YOU CONTRACT CHOLERA
|
A PERSON MAY GET CHOLERA BY DRINKING WATER OR EATING FOOD CONTAMINATED WITH THE CHOLERA BACTERIUM
|
|
WHAT IS THE METHOD FOR ADMINISTERING A TST
|
- MANTOUX METHOD
- PLACED ON THE VOLAR ASPECT OF THE FOREARM - THE BUMP ON THE SKIN IS CALLED A WHEEL |
|
WHAT IS ANOTHER WAY TO TEST FOR TB BESIDES THE TST
|
QUANTIFERON-TB GOLD
(QFT-G) |
|
WHAT CAN BE DONE WHEN PERSONNEL ARE NON-COMPLIANT WRT TB MEDICATION
|
YOU CAN CONSIDER DIRECT OBSERVATION THERAPY
|
|
WHAT IS THE PREFERRED METHOD FOR SUBMISSION OF A MER
|
DRSI (DISEASE REPORTING SYSTEM INTERNET)
|
|
IF THERE IS NO INTERNET HOW ELSE CAN YOU SUBMIT URGERT MER'S
|
- PHONE
- PRIORITY NAVAL MESSAGE - ENCRYPTED EMAIL |
|
WHAT IS DOSAGE SERIES WRT ANTHRAX
|
DAY 0, 4 WEEKS, 6 MONTHS, 12 MONTHS, 18 MONTHS & ANNUAL BOOSTER
|
|
WHAT IS THE MINIMUM INTERVAL WRT HEP B
|
DAYS 0, 1 MONTH & 6 MONTHS
|
|
WHAT IS THE DOSAGE FOR HEP B
|
1.0 CC ADULTS
|
|
WHAT IS THE MINIMUM INTERAL FOR JEV
|
DAY 0, DAY 7 & DAY 30
|
|
WHAT IS THE DOSAGE REQUIREMENT, ROUTE OF ADMINISTRATION AND PERIODICITY FOR JEV
|
- 1.0ML
- SQ - EVERY 3 YEARS |
|
WHAT IS THE DOSAGE FOR THE CHOLERA VACCINE
|
0.5 CC SQ OR IM
|
|
WHAT IS THE DOSAGE FOR THE YELLOW VACCINE
|
0.5 CC SQ
|
|
WHAT PAPERWORK IS GIVEN OUT WHEN ADMINISTERING A VACCINE
|
VACCINE INFORMATION SHEET
|
|
WHAT TYPE OF VACCINES SHOULD NOT BE ROUTINELY ADMINISTERED TO ANY PREGNANT FEMALE
|
LIVE VIRUS VACCINES
|
|
WHAT VACCINES MAY BE ADMINISTERED TO PREGNANT WOMEN IF RISKS OF CONTRACTING ILLNESS OUTWEIGH POTENTIAL COMPLICATIONS
|
POLIO AND YELLOW FEVER
|
|
WHAT COMMITTEE CONSISTS OF EXPERTS IN FIELDS ASSOCIATED WITH IMMUNIZATION, WHO HAVE BEEN SELECTED BY THE SECRETARY OF THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
|
ADVISORY COMMITTEE ON IMMUNIZATIONS PRACTICES (ACIP)
|
